HedgeChatter

  • Home /
  • Tag Archives

IDIX

Idenix Announces Data Presentation at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL)

[at noodls] – CAMBRIDGE, Mass., April 8, 2013 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboardSee who Idenix is hiring next, click here to view […]

April 8, 2013 Bystocknews , Comments Off on Idenix Announces Data Presentation at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL) read more

Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Phase of the Interference

[at noodls] – CAMBRIDGE, Mass., March 22, 2013 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboardSee who Idenix is hiring next, click here to view […]

March 22, 2013 Bystocknews , Comments Off on Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Phase of the Interference read more

Idenix Pharmaceuticals Provides Update on IDX184 and IDX19368 Development Programs

[at noodls] – Management to Host a Conference Call and Webcast Today at 4:30 pm ET CAMBRIDGE, Mass., Feb. 4, 2013 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboardSee who Idenix is hiring next, click here to view […]

February 4, 2013 Bystocknews , Comments Off on Idenix Pharmaceuticals Provides Update on IDX184 and IDX19368 Development Programs read more

Idenix Pharmaceuticals Announces Collaboration With Janssen to Initiate Phase II All-Oral Combination Studies Including IDX719, Simeprevir (TMC435) and TMC647055 for the Treatment of Hepatitis C Virus (HCV)

[at noodls] – CAMBRIDGE, Mass., Jan. 28, 2013 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboardSee who Idenix is hiring next, click here to view […]

January 28, 2013 Bystocknews , Comments Off on Idenix Pharmaceuticals Announces Collaboration With Janssen to Initiate Phase II All-Oral Combination Studies Including IDX719, Simeprevir (TMC435) and TMC647055 for the Treatment of Hepatitis C Virus (HCV) read more

Idenix Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – CAMBRIDGE, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the 31st Annual J.P. Morgan Healthcare … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboardSee who Idenix is hiring next, click here to view […]

January 2, 2013 Bystocknews , Comments Off on Idenix Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference read more

Idenix Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference

[at noodls] – CAMBRIDGE, Mass., Dec. 5, 2012 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Oppenheimer 23rd Annual Healthcare … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboardSee who Idenix is hiring next, click here to view […]

December 5, 2012 Bystocknews , Comments Off on Idenix Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference read more

Idenix Pharmaceuticals to Present at the 2012 Deutsche Bank Access BioFEST Conference

[at noodls] – CAMBRIDGE, Mass., Nov. 26, 2012 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present in a fireside chat at the 2012 Deutsche Bank Access BioFEST … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboard […]

November 26, 2012 Bystocknews , Comments Off on Idenix Pharmaceuticals to Present at the 2012 Deutsche Bank Access BioFEST Conference read more

Idenix Pharmaceuticals Reports Clinical Data for HCV Drug Candidates – IDX719 and IDX184 – at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting

[at noodls] – CAMBRIDGE, Mass., Nov. 10, 2012 (GLOBE NEWSWIRE) — Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboard […]

November 10, 2012 Bystocknews , Comments Off on Idenix Pharmaceuticals Reports Clinical Data for HCV Drug Candidates – IDX719 and IDX184 – at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting read more

PropThink: BioCryst and Presidio’s Priorities May Shift with FDA Concerns

[ACN Newswire] – By Jake KingChalk another nuc up to the FDA’s growing list of safety-related development interruptions. On Tuesday, BioCryst Pharmaceuticals (NASDAQ:BCRX) announced that it has withdrawn an … moreView todays social media effects on IDIXView the latest stocks trending across Twitter. Click to view dashboard […]

October 31, 2012 Bystocknews , Comments Off on PropThink: BioCryst and Presidio’s Priorities May Shift with FDA Concerns read more